Cervical cancer vaccine has reached 80% of India’s girls. In Mumbai, it’s 2%
The national HPV campaign had covered 79.51 per cent of its target by October 14. Maharashtra’s state health department figures show 86,855 girls vaccinated by November 15, reported as just 9 per cent of the state target. The contrast points to a large gap in uptake within the country. Maharashtra ranked 32nd among 36 states and Union Territories in the U-WIN report. Among states targeting more than five lakh girls, it had the lowest coverage. Mumbai’s coverage was lower still: just 2 per cent. Pune stood at 4 per cent, while Wardha led the state’s districts at 25 per cent. The figures show that a national campaign’s reach can vary sharply from place to place. Maharashtra’s health department says it is trying to encourage parents to vaccinate their daughters. Awareness efforts may matter, as officials have pointed to misinformation and vaccine hesitancy. The article gives no later coverage figures to show whether uptake has improved.
How does HPV vaccination coverage in India compare with Maharashtra’s and Mumbai’s?
The national HPV campaign had covered 79.51 per cent of its target by October 14. Maharashtra’s state health department figures show 86,855 girls vaccinated by November 15, reported as just 9 per cent of the state target. The contrast points to a large gap in uptake within the country.
Maharashtra ranked 32nd among 36 states and Union Territories in the U-WIN report. Among states targeting more than five lakh girls, it had the lowest coverage. Mumbai’s coverage was lower still: just 2 per cent. Pune stood at 4 per cent, while Wardha led the state’s districts at 25 per cent.
The figures show that a national campaign’s reach can vary sharply from place to place. Maharashtra’s health department says it is trying to encourage parents to vaccinate their daughters. Awareness efforts may matter, as officials have pointed to misinformation and vaccine hesitancy. The article gives no later coverage figures to show whether uptake has improved.
What factors may help explain why so few girls in Maharashtra are getting vaccinated?
Maharashtra’s low vaccination uptake appears to reflect more than whether sessions are available. The state had conducted over 2.14 lakh sessions, yet had vaccinated only 86,855 girls by November 15. That gap highlights the challenge of turning access to preventive care into families choosing vaccination.
The Indian Express had previously reported that misinformation, including online claims linking the HPV vaccine to infertility, contributed to parental hesitancy. Health officials say awareness campaigns are needed to address such misconceptions. The article also records a striking example: on November 15, just one girl in Nanded received the vaccine across the state, despite 10 sessions being held.
These details suggest that parents’ concerns may be an important barrier, though the article does not establish how much each factor contributes. State official Dr Sandeep Sangale urged parents to come forward and said the department was trying to encourage vaccination. He also cited the absence of reported side-effect cases in states, while the national U-WIN report recorded adverse events.
What is HPV, and how can it cause cervical cancer?
HPV, or human papillomavirus, refers to a group of viruses that can infect people. The article focuses on certain high-risk HPV strains because persistent infection with them can lead to abnormal changes in cells of the cervix. The cervix is the lower part of the uterus.
Most HPV infections do not necessarily become cancer. The key concern is an infection with a cancer-linked type that persists over time. As the article explains, persistent high-risk HPV infection can cause abnormal cervical cells that may eventually develop into cancer. Maharashtra’s Gardasil-4 vaccine targets four HPV types: 6, 11, 16 and 18. Types 16 and 18 account for a substantial proportion of cervical cancer cases.
HPV vaccination and regular screening are both important prevention measures described in the article. The vaccine is aimed at preventing infection from targeted types, while screening can help identify cervical disease. The article reports that Maharashtra is working to increase vaccination and has also deployed screening and diagnostic vans across its administrative divisions.
What could low vaccination coverage mean for future cases of cervical cancer?
HPV vaccination is a preventive measure against infection from the types covered by a vaccine. If coverage remains low, more girls will go without that protection. The concern matters because the article explains that persistent infection with high-risk HPV strains can cause abnormal cervical cell changes that may eventually develop into cancer.
Maharashtra is administering Gardasil-4, which protects against HPV types 6, 11, 16 and 18. The article notes that types 16 and 18 account for a substantial proportion of cervical cancer cases. By November 15, the state had vaccinated 86,855 girls, reported as 9 per cent of its target. Mumbai’s coverage was just 2 per cent.
Low uptake could therefore leave more people vulnerable to future HPV-related disease, but the article does not predict how many future cancer cases might result. Vaccination is only one part of prevention: the state also screens women and operates diagnostic vans. Wider vaccination, along with regular screening, supports the article’s stated aim of preventing cervical cancer.
Why do women still need cervical cancer screening even when an HPV vaccine is available?
An HPV vaccine helps prevent infection with the virus types it targets, but screening remains another important part of cervical cancer prevention. The article describes cervical cancer as largely preventable through vaccination and regular screening. It also reports that Maharashtra continues to screen women through its non-communicable disease programme and dedicated diagnostic vans.
The vaccine used in Maharashtra, Gardasil-4, protects against four HPV types: 6, 11, 16 and 18. The article says types 16 and 18 account for a substantial proportion of cervical cancer cases, but it does not say that the vaccine covers every possible cause or type. Screening, in contrast, can help detect cervical abnormalities or cancer. The state’s vans screened 10,273 women during the period reported.
The article does not give a screening schedule or explain how often an individual woman should be screened. It does show that vaccination and detection are both part of the state’s response. The vans also enabled biopsies and referrals, supporting follow-up when screening identifies a concern.
How can a persistent HPV infection cause healthy cervical cells to become cancerous?
The article gives the central link: persistent infection with high-risk HPV strains can cause abnormal changes in cervical cells, which may eventually develop into cancer. Persistence matters because the infection does not clear quickly, giving abnormal changes time to accumulate. The article does not describe the cell-level steps in detail.
As general biological background, some high-risk HPV types can produce proteins that interfere with normal controls on cell growth and repair. When these controls are disrupted over time, infected cells may keep dividing when they should not. Additional changes can allow abnormal cells to progress toward cancer. This is a possible pathway, not an outcome for every HPV infection.
The article identifies types 16 and 18 as responsible for a substantial proportion of cervical cancer cases and says Maharashtra uses Gardasil-4 against them, as well as types 6 and 11. Vaccination can prevent infection from targeted types, while regular screening can help detect abnormal cervical cells. The state’s screening programme and diagnostic vans are part of that early-detection effort.
How does a vaccine train the immune system to fight an infection before it causes disease?
A vaccine trains the immune system to recognize a germ or part of it without needing to wait for the disease to develop. This answer draws on established biology; the article does not explain how vaccines work. The aim is to give the body a safer opportunity to prepare its defenses in advance.
In general, a vaccine prompts the immune system to make antibodies and other responses that recognize the targeted germ. Some immune cells retain a memory of that target. If the person later encounters it, the immune system can respond more quickly and effectively, reducing the chance of illness or severe disease. The precise response varies by vaccine and infection.
The article describes Maharashtra’s free HPV campaign as aimed at 14-year-old girls and says the vaccine used, Gardasil-4, protects against HPV types 6, 11, 16 and 18. It does not detail the vaccine’s immune mechanism. Its prevention goal is to reduce infection with those types, which can contribute to cervical cancer, while regular screening remains important.
This brief was written by AI from the original reporting and checked by other models. Names, figures and quotes come from the source; read it for full context.
Read more in the JupiteX app
Pulse is free. New stories every 4 hours, each one broken into the questions that explain it.
Or read more news on the web